Nasdaq
IKT
Inhibikase Therapeutics, Inc.
- Health Care
- Listed 2020
- 1 day
- +0.4%
- 1 month
- +17.6%
- 1 year
- +39.3%
$2.41 · Mkt cap $318M
At the 6 Aug 2026 close
Nasdaq
Inhibikase Therapeutics, Inc.
$2.41 · Mkt cap $318M
At the 6 Aug 2026 close
Inhibikase Therapeutics, Inc. trades under the ticker IKT on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2020. Its market capitalisation is $318M. The last closing price was $2.41, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +39.3%, and +17.6% over the past month. Returns are price returns and exclude dividends.
This page exists because IKT is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.